IRadimed

IRadimed OCF Margin

The Operating Cash Flow Margin of IRadimed (IRMD) as of Oct 10, 2026 is 29.76 %. In the previous year, Operating Cash Flow Margin was 34.99 % — a change of -14.92% (lower).

OCF Margin

29.76 %

YoY

-14.92%

Last updated:

Operating Cash Flow Margin of IRadimed is 2025 29.76 % . Operating Cash Flow Margin of IRadimed was 2024 34.99 % . It decreases by -14.92% lower compared to the previous year.

The IRadimed OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
24.23 USD
Jan 1, 2019
26.57 USD
Jan 1, 2020
18.34 USD
Jan 1, 2021
26.92 USD
Jan 1, 2022
18.84 USD
Jan 1, 2023
20.54 USD
Jan 1, 2024
34.99 USD
Jan 1, 2025
29.76 USD
The IRadimed OCF Margin history
YEAROCF MarginYoY
29.76 %-14.92%
34.99 %+70.35%
20.54 %+9.01%
18.84 %-30.02%
26.92 %+46.79%
18.34 %-30.96%
26.57 %+9.63%
24.23 %+63.74%
14.80 %-48.87%
28.95 %+19.55%
24.21 %+46.57%
16.52 %—
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

Operating Cash Flow Margin of IRadimed is 29.76 % in 2025.

Operating Cash Flow Margin of IRadimed changed from 34.99 % to 29.76 %, representing a -14.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin IRadimed since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's IRadimed with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — IRadimed

All Key Metrics — IRadimed